Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: A National Cancer Institute conference, 2008. ,
Radiotherapy of invasive breast cancer: French national guidelines, Cancer/Radiothérapie, vol.16, pp.503-513, 2012. ,
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). 2011. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials, Lancet, vol.378, pp.1707-1716 ,
Early Breast Cancer Trialists ,
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomized trials, Lancet, issue.9935, pp.383-2127, 2014. ,
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation, J Clin Oncol, vol.20, issue.1, pp.17-23, 2002. ,
T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy, Int J Radiat Oncol Biol Phys, vol.59, issue.1, pp.138-145, 2004. ,
Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy, Int J Radiat Oncol Biol Phys, vol.62, issue.2, pp.351-357, 2005. ,
Impact of chemotherapy sequencing on localregional failure risk in breast cancer patients undergoing breast-conserving therapy, Ann Surg, vol.257, issue.2, pp.173-179, 2013. ,
Predictors of locoregional outcome in patients receiving neoadjuvant therapy and post mastectomy radiation, Cancer, vol.119, issue.1, pp.16-25, 2013. ,
Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy, Ann Surg Oncol, vol.23, issue.3, pp.749-756, 2016. ,
Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment, Cancer Res Treat, 2016. ,
Preoperative Chemotherapy in Patients with Operable Breast Cancer: Nine-Year Results from National Surgical Adjuvant Breast and Bowel Project B-18, J Natl Cancer Inst Monogr, vol.30, pp.96-102, 2001. ,
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27, J Clin Oncol, vol.24, pp.2019-2027, 2006. ,
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27, J Clin Oncol, issue.32, pp.30-3960, 2012. ,
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system, J Clin Oncol, issue.15, pp.25-2127, 2007. ,
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer, Ann Oncol, vol.22, pp.1736-1747, 2011. ,
Post mastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy, J Clin Oncol, issue.23, pp.22-4691, 2004. ,
Post mastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy, Int J Radiat Oncol Biol Phys, vol.68, issue.4, pp.1004-1009, 2007. ,
Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer, Int J Radiat Oncol Biol Phys, vol.81, issue.3, pp.782-787, 2011. ,
Herceptin Adjuvant (HERA) Trial Study Team Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4- year follow-up of a randomised controlled trial, Lancet Oncol, vol.12, pp.236-244, 2011. ,
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step, Ann Oncol, vol.25, pp.1128-1136 ,
Evaluation of the MD Anderson Prognostic Index for localregional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy, Ann Surg Oncol, vol.19, issue.3, pp.901-907, 2012. ,
Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI, Breast Cancer Res Treat, vol.72, issue.2, pp.145-152, 2002. ,
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial, J Clin Oncol, issue.22, pp.25-3259, 2007. ,
European Organization for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups. 2015. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomized phase III trial, Lancet Oncol, vol.16, issue.1, pp.47-56 ,
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27, J Clin Oncol, vol.24, pp.2019-2027, 2006. ,
SBU-group. Swedish Council of Technology Assessment in Health Care A systematic overview of chemotherapy effects in breast cancer, Acta Oncol, vol.40, pp.253-281, 2001. ,
Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies, J Clin Oncol, vol.32, pp.3883-3891, 2014. ,
Radiotherapy of invasive breast cancer: French national guidelines, Cancer/Radiothérapie, vol.16, pp.503-513, 2012. ,
Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study, J Clin Oncol, vol.33, issue.3, pp.258-264, 2015. ,
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step, Ann Oncol, vol.25, pp.1128-1136 ,
Alliance for Clinical Trials in Oncology, Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial, pp.310-1455, 2013. ,
Benefit of taxanes as adjuvant chemotherapy for early breast cancer: pooled analysis of 15,500 patients, Cancer, vol.106, pp.2337-2344, 2006. ,
Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks, Cancer, issue.6, pp.98-1150, 2003. ,
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: A National Cancer Institute conference, J Clin Oncol, vol.26, issue.5, pp.791-797, 2008. ,
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation, J Clin Oncol, vol.20, issue.1, pp.17-23, 2002. ,
Adjuvant radiation therapy of regional lymph nodes in breast cancer -a meta-analysis of randomized trials-an update, Radiat Oncol, vol.10, p.258, 2015. ,
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy, Breast Cancer Res, vol.14, issue.3, p.83, 2012. ,
Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience, J Clin Oncol, issue.12, pp.22-2303, 2004. ,
Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer, J Clin Oncol, vol.13, pp.314-322, 1995. ,
Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015, Ann Oncol, issue.8, pp.26-1533, 2015. ,
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). 2011. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials, Lancet, vol.378, pp.1707-1716 ,
Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy, Int J Radiat Oncol Biol Phys, vol.78, issue.2, pp.337-342, 2010. ,
Management of locally advanced breast cancer (stage III): a review, Int Adv Surg Oncol, vol.7, pp.297-327, 1984. ,
Cancer survival in Europe 1999???2007 by country and age: results of EUROCARE-5???a population-based study, The Lancet Oncology, vol.15, issue.1, pp.23-34, 2014. ,
DOI : 10.1016/S1470-2045(13)70546-1
Taxanes for adjuvant treatment of early breast cancer, Cochrane Database Syst Rev, issue.4, p.4421, 2007. ,
Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18, Cancer, vol.95, pp.681-695, 2002. ,
Athena Breast Health Network. 2012. Role of post mastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer, Int J Radiat Oncol Biol Phys, vol.83, issue.2, pp.494-503 ,
Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis, PLoS One, vol.9, issue.9, p.105316, 2014. ,
Influence of neoadjuvant chemotherapy on radiotherapy for breast cancer, Ann Surg Oncol, vol.22, issue.5, pp.1434-1440, 2015. ,
T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy, Int J Radiat Oncol Biol Phys, vol.59, issue.1, pp.138-145, 2004. ,
A systematic review of taxane-containing regimens for metastatic breast cancer, Br J Cancer, vol.93, pp.293-301, 2005. ,
Herceptin Adjuvant (HERA) Trial Study Team Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial, Lancet Oncol, vol.12, pp.236-244, 2011. ,
Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomized controlled superiority trial with a parallel HER2-negative cohort, Lancet Oncol, vol.15, pp.640-647, 2014. ,
Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?, Cancer Invest, vol.28, issue.2, pp.195-200, 2010. ,
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013, Ann Oncol, vol.24, pp.2206-2223, 2013. ,
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer, Ann Oncol, vol.22, pp.1736-1747, 2011. ,
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer, J Clin Oncol, vol.21, pp.976-983, 2003. ,
Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy, 2013. ,
Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy, Eur J Cancer, vol.48, pp.3342-3354, 2012. ,
Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score, Int J Radiat Oncol Biol Phys, vol.66, issue.2, pp.352-357, 2006. ,
Post mastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy, J Clin Oncol, issue.23, pp.22-4691, 2004. ,
Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy, Int J Radiat Oncol Biol Phys, vol.62, issue.2, pp.351-357, 2005. ,
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system, J Clin Oncol, issue.15, pp.25-2127, 2007. ,
Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials, Breast Cancer Res Treat, vol.134, pp.903-913, 2011. ,
Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment, Cancer Res Treat, 2016. ,
Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation, J Clin Oncol, issue.15, pp.18-2817, 2000. ,
The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy, Int J Radiat Oncol Biol Phys, issue.3, pp.50-735, 2001. ,
Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis, Acad Radiol, vol.16, issue.5, pp.551-563, 2009. ,
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicenter cohort study, Lancet Oncol, issue.7, pp.14-609, 2013. ,
Quels volumes d'irradiation ganglionnaire après chimiothérapie néoadjuvante des cancers du sein ?, Cancer/Radiothérapie, vol.19, pp.271-275, 2015. ,
Radiotherapy for Stage II and Stage III Breast Cancer Patients With Negative Lymph Nodes After Preoperative Chemotherapy and Mastectomy, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.1, pp.1-7, 2012. ,
DOI : 10.1016/j.ijrobp.2010.12.054
Aggressive combined modality therapy for advanced local-regional breast carcinoma, J Clin Oncol, vol.2, issue.3, pp.157-163, 1984. ,
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27, J Clin Oncol, issue.32, pp.30-3960, 2012. ,
Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28, J Clin Oncol, vol.23, pp.3686-3696, 2005. ,
Reducing local therapy in patients responding to preoperative systemic therapy: are we outsmarting ourselves?, J Clin Oncol, vol.32, issue.6, pp.491-493, 2014. ,
Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis, J Natl Cancer Inst, vol.97, pp.188-194, 2005. ,
Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy, J Natl Cancer Inst, vol.105, pp.321-333, 2013. ,
Early Breast Cancer Trialists' Collaborative Group. 2014. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomized trials, Lancet, issue.9935, pp.383-2127 ,
Post mastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy, Int J Radiat Oncol Biol Phys, vol.68, issue.4, pp.1004-1009, 2007. ,
Preoperative chemotherapy for women with operable breast cancer, Cochrane Database Syst Rev, vol.27, issue.5, p.5002, 2007. ,
DOI : 10.1002/14651858.CD005002.pub2
Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy, Ann Surg, vol.257, issue.2, pp.173-179, 2013. ,
Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer, Int J Radiat Oncol Biol Phys, vol.81, issue.3, pp.782-787, 2011. ,
A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility, Ann Surg Oncol, vol.9, issue.3, pp.228-234, 2002. ,
Danish Breast Cancer Cooperative Group 82b Trial. 1997. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy, N Engl J Med, issue.14, pp.337-949 ,
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial, Lancet, issue.9165, pp.353-1641, 1999. ,
Molecular portraits of human breast tumors, Nature, vol.406, pp.747-752, 2000. ,
EORTC Radiation Oncology and Breast Cancer Groups. 2015. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer, N Engl J Med, vol.373, issue.4, pp.317-327 ,
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group, J Clin Oncol, issue.6, pp.17-1689, 1999. ,
Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial, J Clin Oncol, vol.24, pp.5664-5671, 2006. ,
Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response, J Clin Oncol, vol.13, pp.1152-1159, 1995. ,
Place de la radiothérapie après chimiothérapie première dans le cancer du sein, Cancer Radiother, vol.18, issue.3, pp.229-263, 2014. ,
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.26, issue.5, pp.8-30 ,
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci, vol.98, pp.10869-10874, 2001. ,
Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy, Ann Surg Oncol, vol.23, issue.3, pp.749-756, 2016. ,
Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials, J Clin Oncol, issue.21, pp.22-4247, 2004. ,
DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer, J Clin Oncol, vol.34, issue.4, pp.314-320, 2016. ,
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer, J Clin Oncol, vol.13, pp.2886-2894, 1995. ,
Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902, Journal of Clinical Oncology, vol.19, issue.22, pp.19-4224, 2001. ,
DOI : 10.1200/JCO.2001.19.22.4224
EORTC Breast Cancer Group Tailored follow-up for early breast cancer patients: a prognostic index that predicts locoregional recurrence, 2010. ,
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes, Journal of Clinical Oncology, vol.30, issue.15, pp.1796-1804, 2012. ,
DOI : 10.1200/JCO.2011.38.8595
International Breast Cancer Study Group Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII, J Clin Oncol, vol.21, issue.7, pp.1205-1213, 2003. ,
Predictive Value of Molecular Subtyping for Locoregional Recurrence in Early-Stage Breast Cancer with N1 without Post Mastectomy Radiotherapy, J Breast Cancer, vol.19, issue.2, pp.176-184, 2016. ,
Preoperative Chemotherapy in Patients with Operable Breast Cancer: Nine-Year Results from National Surgical Adjuvant Breast and Bowel Project B-18, J Natl Cancer Inst Monogr, vol.30, pp.96-102, 2001. ,
Predictors of locoregional outcome in patients receiving neoadjuvant therapy and post mastectomy radiation, Cancer, vol.119, issue.1, pp.16-25, 2013. ,
Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer, Br J Surg, issue.5, pp.93-539, 2006. ,